Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Asia Pacific (Supplemental) | 2018 | Market Analysis

IC procedure volumes will grow rapidly in the Asia Pacific region, stemming from economic growth and favorable demographics. Although the IC device market will be limited by falling ASPs and slow adoption of premium-priced devices, it will experience overall expansion through 2026.

This Medtech 360 Report provides high-level market metrics for IC devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…
Report
Dental Implants – Market Insights – Asia Pacific
The Asia Pacific dental implant market will grow strongly over the forecast period. Demand for dental implants is rising, driven by the aging population, increased oral health awareness, and higher…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…